Scott Ferguson of Sachem is long Akorn.

You could say that the managing partner of Sachem Head Capital Management is quite bullish on Akron. The money manager told conference attendees that shares of the eye-care product maker could double within the next two years. He also said that the company could be a target of drug giant Mylan or its former takeover target Perrigo.

First « 1 2 3 4 5 6 7 8 » Next